Osteochondral Talar Lesions and Defects
Keywords
• Talar dome lesions • Ostrochondral defects • Talus fracture • Ankle arthritis
Key Points
Introduction
Osteochondral defects of the talar dome have been documented in the literature under various names since first being described by Alexander Monro in 1738.1 Perhaps the name we are most familiar with, osteochondritis dissecans (OCD), coined in 1888 by Konig, is an inappropriate term nowadays given the lack of scientific support for inflammation as the causative factor in cartilage separation of talar dome lesions (TDL).2 In addition, medical documentation of OCD is often misconstrued as the abbreviation for the mental condition of obsessive compulsive disorder, which can result in medical legal issues if misinterpreted by a third party. The term flake fracture is true in Berndt-Harty stage II, III, and IV lesions, but would be inaccurate as terminology in stage I lesions or subchondral cyst. Osteochondral lesion of the talus (OLT) is perhaps more accurate; however, it fails to address which of the 3 joints of the talus is being referred to. Regardless of antiquated or misleading nomenclature, TDL have increasingly been the focus of interest and training of many foot and ankle surgeons over the past decade.
Why the increased interest in TDL, if statistical literature indicates TDL only accounts for 0.09% of all fractures and only 1% of talus fractures?3 The answer, simply put, is more than 1 in 20 ankle sprains and more than 1 in 4 ankle fractures will develop a TDL, which is a large volume of patients in a foot and ankle specialty practice.2 Statistics are based on properly diagnosed cases, and fail to take into account undiagnosed incidence. Hence, the most important treatment aspect of TDL is diagnosis, so that appropriate treatment protocols can be enacted in a timely and stepwise manner. Once diagnosis is made, appropriate treatment with either conservative or surgical management can begin. By being aware of all practical treatment options and their indications, success rates, benefits, risks, and alternative options, foot and ankle specialists will be able to make an informed decision on appropriate care selection after perusing this article.
Anatomy of the talus
The articular surface of the talar dome is covered with a thin layer of avascular hyaline cartilage that receives nourishment from the articular fluid. Cartilage thickness ranges from 1.11 (±0.28 mm) in women and 1.35 (±0.22 mm) in men on the talar dome.4 The hyaline cartilage consist of chondrocytes that lie in groupwise lacunae of the extracellular matrix it produces, composed of collagen, hyaluronic acid, proteoglycans, and a small amount of glycoproteins.5
Etiology of osteochondral talar lesions and defects
Berndt and Harty,6 using cadaveric models, were able to recreate TDL and correlate lesion location with causative forces. By dorsiflexing the foot at the ankle and placing the talus in complete contact with the medial and lateral malleoli and tibial plafond followed by applying an inversion force to the foot, they were able to force the talus against its fibular articulation and create lateral TDL. In addition, by plantarflexing the foot at the ankle and placing the posterior aspect of the medial axilla of the talus in direct contact with the tibia by relaxing the collateral ligaments and placing the narrow aspect of the talar dome in the ankle joint by applying an inversion force, they were able to reproduce medial lesions. As a general rule, lateral lesions are located anteriorly and are small, shallow, and wafer-shaped because of shearing force, whereas medial lesions are located posteriorly or centrally and are larger, cup-shaped, and deep, caused by torsional impact.7 Because of their shape, lateral lesions are more likely than medial lesions to displace.8 Lesions may also be iatrogenically induced during surgical intervention by inappropriately inserted or manipulated arthroscopic equipment, or with internal or external fixation of ankle fractures from malpositioned drills, screws, or pins.
Classification of talar dome lesions
Classically lesions have been classified as 1 of 4 types for the past 50 years, using the Berndt and Hardy classification system based on radiographic findings.6 In 2001, Scranton and McDermott9 proposed their addition of a stage V lesion to the Berndt and Hardy classification system to describe a cystic lesion. Anderson and colleagues and Ferkel and colleagues10,11 both developed classification systems using magnetic resonance imaging (MRI). Loomer and colleagues12 developed a classification system using computed tomography (CT) imaging. Pritsch and colleagues13 developed a classification system based on arthroscopic appearance of articular ankle cartilage.
Clinical Examination
The reason TDL are missed in some patients is perhaps because the subjective complaints of pain or ankle limitations expressed by the patient are not matched by significant objective findings recognized by the physician. Clinical examination should follow the key podiatric components of a foot and ankle examination with special care to a few details. In reviewing the vascularity, attention should be directed to identifying excessive edema, particularly when compared with the contralateral uninvolved extremity in both acute and chronic conditions. In acute conditions, bruising and formation of fracture blisters may be present, indicating additional injury such as ankle sprain or fracture. Dermatologic conditions are generally limited or nonexistent except for acute fracture blisters, or skin irritation from shoe gear or bracing owing to ankle instability. Atypical skin presentations may represent either comorbid skin issues, or differential diagnosis such as psoriatic arthritis. Neurologic findings include pain out of proportion for palpation, ambulation, and range of motion. The majority of notable issues will be related to the musculoskeletal examination. Pain with palpation of the anteromedial and anterolateral margins of the ankle joint, and possibly at the posteromedial aspect, are generally found with TDL; however, lack of pain in these areas does not exclude a TDL.2 Range of motion actively and passively may have a clicking sound with popping sensation with or without severe pain to the patient, as the fragment or defect catches in the joint, affecting smooth normal motion. Gait analysis may demonstrate limping, guarding, and instability of the affected limb in symptomatic patients. TDL may be asymptomatic or limited in severity, with no clinical manifestations.
Imaging for Talar Dome Lesions
Plain radiography
Additional beneficial ankle views may include a 4-cm heel lift, which plantarflexes the foot, allowing for some posterior TDL to be better visualized.14 Stress inversion and anterior drawer may indicate ligamentous injury and can help confirm the probability of ankle sprain leading to TDL.
Radiographs, however, are limited in their ability to readily identify TDL and may not visualize 30% to 43% of lesions.3,14,15 Plain radiographs are limited by their ability to predominately only visualize osseous bone structures and are not able to visual noncalcified cartilage structures. As a result, TDL that only involve cartilage surfaces may not readily be identified until they progress with time to cause cystic bone lesions to appear as radiopaque lesions. Serial radiographs may be needed with several weeks to months between series before a TDL is evident.
Computed tomography
CT examinations have been considered by many to be the preferred method of definitely evaluating TDL before surgical intervention, as the lesion can be evaluated in multiple planes. CT allows for detailed evaluation of the osseous component of the TDL to measure lesion size and location. To obtain optimal imaging of a TDL with CT, the imaging protocol calls for ultrahigh-resolution axial slices with 0.3-mm increments and 0.6-mm thickness, with 1-mm coronal and sagittal multiplanar reconstruction.8 CT is limited due to its decreased ability to characterize and visualize the cartilage component of the TDL, which can be rather problematic when evaluating Berndt-Harty stage I lesions.16 CT can generally be performed on a larger population of patients than can MRI, because one is able to perform CT on patients who have pacemaker/defibrillator implantation or ferrous or unknown metal foreign bodies, both of which are contraindications for MRI. CT may be the preferred advanced diagnostic imaging method if additional osseous structures such as the tibia and fibula are in question, such as in a comminuted ankle fracture. CT scans are generally preferred when a TDL is already known to be present and surgical intervention is pending.
Magnetic resonance imaging
MRI is considered the preferred tool for diagnosis and preoperative planning for TDL by the majority of remaining physicians. Like CT, MRI allows the lesion to be evaluated in multiple planes. MRI has the ability not only to visualize osseous defects (perhaps not to the degree of CT) but also to give greater detail with regard to cartilage integrity. Unlike CT, MRI generally allows Berndt-Harty stage I lesions to be detected, and findings have been found to correlate closely with arthroscopically visualized findings for cartilage defects.16 MRI may be the preferred advanced diagnostic imaging method if additional soft-tissue structures such as the ankle ligaments are in question, such as in a severe sprain. MRI scans are generally preferred when a TDL is suspected but not already definitely identified.
Bone scintigraphy (3-phase bone scan)
Bone scintigraphy can be used as a screening tool to help detect the potential presence of TDL when plain radiography is inconclusive. Studies have shown bone scintigraphy to be 94% sensitive and 96% specific for TDL when abnormal uptake in the talar dome was noted on at least one view by Urman and colleagues.17 Although bone scintigraphy may be helpful in indicating whether a TDL is present, it provides little information on size, location, and severity, and therefore should be followed by a more definitive imaging modality such as CT or MRI before surgical planning.
Conservative nonoperative treatment of osteochondral talar lesions and defects
Conservative nonoperative care should generally be the initial line of care for most TDL. Surgery is necessitated when a patient has failed the standard length and course of nonoperative care. Berndt-Harty stage I and II TDL have the best prognosis, with 90% resolution with nonoperative care, and can be managed nonsurgically for up to 12 months before initiating surgical options.16,18 Expert recommendations from long-term follow-up studies by individuals treating all 4 Berndt-Harty grade lesions indicate that stage I or II medial or lateral, and stage III medial lesions can initially be treated with conservative nonoperative care; however, stage III lateral and stage IV medial or lateral lesions should proceed to surgical intervention.7,18
Protective Weight-Bearing Devices and Strapping
Bracing, strapping, or taping combined with protected early ankle motion may allow for Berndt-Harty stage I TDL to resolve to tolerable levels after several weeks to months. Berndt-Harty stage II lesions may resolve with 1 to 1 and a half months of immobilization with a 3D immobilization boot, CAM walker boot, or short leg walking cast; the same treatment for up to 4 and a half months has also been shown to be beneficial in stage III medial lesions.7